These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3893084)

  • 21. [Drugs for rectal administration (a review of the literature)].
    Golovkin VA; Peshekhonova LL; Lukash EP
    Vrach Delo; 1984 Nov; (11):7-11. PubMed ID: 6396948
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2007; 62(3):80-4. PubMed ID: 17955956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drugs that should not be triturated].
    Fernández Contreras V
    Rev Enferm; 1992; 15(167-168):22-4. PubMed ID: 1641559
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral depot preparations].
    Pedersen AO
    Tidsskr Nor Laegeforen; 1973 Dec; 93(34):2497-8. PubMed ID: 4771159
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioavailability and stability of erythromycin delayed release tablets.
    Ogwal S; Xide TU
    Afr Health Sci; 2001 Dec; 1(2):90-6. PubMed ID: 12789122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioequivalence of solid drug preparation].
    Ejima A
    Eisei Shikenjo Hokoku; 1982; (100):1-20. PubMed ID: 6897833
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
    Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulations and dosages of oral drugs.
    Calesnick B
    Am Fam Physician; 1978 Sep; 18(3):160-2. PubMed ID: 685796
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study, outline and formulation of pharmaceutical preparations with delayed action].
    Arancibia A
    Farmaco Prat; 1972 Apr; 27(4):181-204. PubMed ID: 5022155
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bioequivalency of salazosulfapyridine tablets].
    Gafiţanu E; Matei I; Braha S; Vasilescu M; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):123-5. PubMed ID: 2899340
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease.
    de Montalembert M; Bachir D; Hulin A; Gimeno L; Mogenet A; Bresson JL; Macquin-Mavier I; Roudot-Thoraval F; Astier A; Galactéros F
    Haematologica; 2006 Dec; 91(12):1685-8. PubMed ID: 17145606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report.
    Skelly JP; Van Buskirk GA; Savello DR; Amidon GL; Arbit HM; Dighe S; Fawzi MB; Gonzalez MA; Malick AW; Malinowski H
    J Parenter Sci Technol; 1993; 47(2):52-6. PubMed ID: 8515344
    [No Abstract]   [Full Text] [Related]  

  • 35. How do I administer medication by NG?
    Birdsall C; Uretsky S
    Am J Nurs; 1984 Oct; 84(10):1259-60, 1284. PubMed ID: 6435450
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug delivery systems.
    Polack AE; Roberts MS
    Med J Aust; 1986 Mar; 144(6):311-4. PubMed ID: 3713622
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissolution of drugs from solid dosage forms. I. General aspects.
    Arayne MS; Sultana N
    J Pak Med Assoc; 1979 Sep; 29(9):193-200. PubMed ID: 117153
    [No Abstract]   [Full Text] [Related]  

  • 38. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative human pharmacokinetic studies of 20 mg nifedipine-containing Cordaflex and Adalat film coated retared tablets].
    Klebovich I; Horvai G; Grézal G; Baloghné NK; Horváth V; Kocsi E; Balogh J; Cseh A; Farsang C
    Acta Pharm Hung; 1996 Jan; 66(1):29-39. PubMed ID: 8714363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of valproic acid obtained after administration of three oral formulations to humans.
    Bialer M; Hussein Z; Dubrovsky J; Raz I; Abramsky O
    Isr J Med Sci; 1984 Jan; 20(1):46-9. PubMed ID: 6421770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.